6505--japanese encephalitis virus vaccine ixiaro

Award Notice Posted

Solicitation number
36C25227N0099
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
36F79725D024936C25227N0099

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 12 awarded a $787,392 delivery order to Valneva USA, Inc. for Japanese Encephalitis Virus Vaccine (IXIARO) on October 1, 2026.

The order was placed against FSS Contract 36F79725D0249 under limited competition. IXIARO is the only Japanese encephalitis vaccine licensed and available for use in the United States; the award was justified under GSAR 538.7104-4 for items peculiar to one manufacturer. The vaccine is manufactured by Valneva Scotland Ltd. in Livingston, Scotland and distributed by Valneva USA, Inc. from Bethesda, Maryland. The contracting officer, Stacy Massey (Network Contracting Office 12, Milwaukee, Wisconsin), determined pricing fair and reasonable and found the procurement to represent best value and lowest overall cost. The vaccine supports Captain James A. Lovell Federal Healthcare Center in North Chicago, Illinois and is required for Navy recruits prior to deployment.

Notice text

Awarded contract 36F79725D024936C25227N0099 to VALNEVA USA, INC. for 787392.00 on 2026-10-01.

Files

File Type Posted
GSAR 538 Limiting_Sources_Justification_OVER_SAT.pdf PDF
36F79725D0249 36C25227N0099_1.docx DOCX document

Notice history

Notice Type Posted
6505--japanese encephalitis virus vaccine ixiaro Latest Award Notice
This notice Award Notice
6505--japanese encephalitis virus vaccine ixiaro Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors